SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-22-006207
Filing Date
2022-05-16
Accepted
2022-05-16 16:12:59
Documents
66
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_033122.htm   iXBRL 10-Q 1130312
2 CERTIFICATIONS ex31-1.htm EX-31.1 10354
3 CERTIFICATIONS ex31-2.htm EX-31.2 10525
4 CERTIFICATIONS ex32-1.htm EX-32.1 4548
5 CERTIFICATIONS ex32-2.htm EX-32.2 5187
  Complete submission text file 0001387131-22-006207.txt   5350273

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE admp-20220331.xsd EX-101.SCH 39648
7 XBRL CALCULATION FILE admp-20220331_cal.xml EX-101.CAL 79728
8 XBRL DEFINITION FILE admp-20220331_def.xml EX-101.DEF 160905
9 XBRL LABEL FILE admp-20220331_lab.xml EX-101.LAB 364577
10 XBRL PRESENTATION FILE admp-20220331_pre.xml EX-101.PRE 286270
60 EXTRACTED XBRL INSTANCE DOCUMENT admp-10q_033122_htm.xml XML 712940
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 22929130
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences